1. Home
  2. WMK vs MLTX Comparison

WMK vs MLTX Comparison

Compare WMK & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weis Markets Inc.

WMK

Weis Markets Inc.

N/A

Current Price

$72.39

Market Cap

1.8B

ML Signal

N/A

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

N/A

Current Price

$12.11

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WMK
MLTX
Founded
1912
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
WMK
MLTX
Price
$72.39
$12.11
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$27.50
AVG Volume (30 Days)
123.4K
1.2M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
1.96%
N/A
EPS Growth
N/A
N/A
EPS
2.05
N/A
Revenue
$4,714,573,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$35.15
N/A
Revenue Growth
0.01
N/A
52 Week Low
$59.99
$5.95
52 Week High
$83.74
$62.75

Technical Indicators

Market Signals
Indicator
WMK
MLTX
Relative Strength Index (RSI) 50.08 21.38
Support Level $67.85 $11.06
Resistance Level $72.51 $19.24
Average True Range (ATR) 1.57 0.66
MACD 0.40 -0.21
Stochastic Oscillator 66.58 4.79

Price Performance

Historical Comparison
WMK
MLTX

About WMK Weis Markets Inc.

Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: